5th Wet AMD and Diabetic Eye Disease Drug Summit
14 14 people viewed this event.
Global biopharmaceutical leaders continue to make significant strides in retinal disease treatments; as Bayer and Regeneron make headway with its high-dose version of Eylea (Eylea HD), Roche’s Vabysmo is providing strong competition and has rapidly increased its market share across wet AMD and DME.
Date and Time: Tuesday, 18 March 2025 at 08:00 to Thursday, 20 March 2025 at 16:20
Venue details: Revere Hotel Boston Common, 200 Stuart Street, Boston, Massachusetts, 02116, United States
Contact Person - Eden Chau
Email - info@hansonwade.com
Organizer - Hanson Wade